News & Updates

Show Multimedia Only

Study highlights potential link between VOCs and CVD, mortality

20 Apr 2026

Exposure to volatile organic compounds (VOCs) may be associated with increased risks of cardiovascular disease (CVD) and CVD death, as suggested in a systematic review and meta-analysis.

Study highlights potential link between VOCs and CVD, mortality

20 Apr 2026

COVID-19 ups new-onset respiratory T2ID risk

20 Apr 2026 by

A study shows an association between COVID-19 infection and an elevated risk of new-onset respiratory type 2 inflammatory diseases (T2IDs), while vaccination remains protective against such diseases.

COVID-19 ups new-onset respiratory T2ID risk

20 Apr 2026

Young adults with glomerular disease at increased risk of cancer

19 Apr 2026

Glomerular disease is associated with an increased risk of cancer, particularly among younger patients who are typically excluded from screening programs, according to a retrospective study.

Young adults with glomerular disease at increased risk of cancer

19 Apr 2026

Anti-TNF–experienced HS patients respond well to povorcitinib

19 Apr 2026 by

The oral JAK1 inhibitor povorcitinib elicits clinical response in the subpopulation of hidradenitis suppurativa (HS) patients who had prior treatment with anti-TNF, according to pooled 24-week data from the phase III STOP-HS trials.

Anti-TNF–experienced HS patients respond well to povorcitinib

19 Apr 2026

Fluvoxamine improves fatigue, QoL in long COVID patients

19 Apr 2026 by

Patients with long COVID may derive benefits from treatment with fluvoxamine, which has been shown to reduce fatigue and improve quality of life (QoL) in a study. The use of metformin, on the other hand, shows no significant advantage.

Fluvoxamine improves fatigue, QoL in long COVID patients

19 Apr 2026

IBD risk high in individuals with certain allergic diseases

19 Apr 2026

Individuals with atopic dermatitis or allergic rhinitis are at increased risk of inflammatory bowel disease (IBD), as suggested in a retrospective nested case–control study.

IBD risk high in individuals with certain allergic diseases

19 Apr 2026

Ultrasound-facilitated, catheter-directed thrombolysis beneficial in intermediate-risk PE

18 Apr 2026 by

In the treatment of patients with acute, intermediate-risk pulmonary embolism (PE), administering ultrasound-facilitated, catheter-directed thrombolysis (USCDT) on top of anticoagulation results in better short-term outcomes compared with anticoagulation alone, as shown in the multinational, adaptive-design, open-label HI-PEITHO trial.

Ultrasound-facilitated, catheter-directed thrombolysis beneficial in intermediate-risk PE

18 Apr 2026

Cannabis may reduce risk of some skin cancers

18 Apr 2026 by

The use of cannabis appears to result in a lower incidence of basal cell carcinoma (BCC) over 10 years, but not cutaneous squamous cell carcinoma (cSCC) or malignant melanoma (MM), suggests a recent study presented at AAD 2026.

Cannabis may reduce risk of some skin cancers

18 Apr 2026

Transcatheter ViV may be a safe short-term option to repeat MVR

18 Apr 2026 by

The transcatheter valve-in-valve (ViV) procedure appears to be a safe option for select patients requiring repeat surgery after failed mitral bioprostheses, according to findings from the randomized controlled SURViV trial presented at ACC.26. However, it is still early days for the ViV approach.

Transcatheter ViV may be a safe short-term option to repeat MVR

18 Apr 2026

Roflumilast cream effective in Chinese patients with plaque psoriasis

18 Apr 2026 by

Once-daily application of roflumilast cream 0.3% is associated with a significantly higher rate of treatment success on the Investigator's Global Assessment (IGA) scale in Chinese patients with plaque psoriasis compared with a vehicle cream, according to the phase III DERMIS-1 and -2 studies presented at AAD 2026.

Roflumilast cream effective in Chinese patients with plaque psoriasis

18 Apr 2026

News & Updates

Showing Multidisciplinary articles

Showing

Specialty:

Study highlights potential link between VOCs and CVD, mortality

Study highlights potential link between VOCs and CVD, mortality

COVID-19 ups new-onset respiratory T2ID risk

COVID-19 ups new-onset respiratory T2ID risk

Young adults with glomerular disease at increased risk of cancer

Young adults with glomerular disease at increased risk of cancer

Anti-TNF–experienced HS patients respond well to povorcitinib

Anti-TNF–experienced HS patients respond well to povorcitinib

Fluvoxamine improves fatigue, QoL in long COVID patients

Fluvoxamine improves fatigue, QoL in long COVID patients

IBD risk high in individuals with certain allergic diseases

IBD risk high in individuals with certain allergic diseases

Ultrasound-facilitated, catheter-directed thrombolysis beneficial in intermediate-risk PE

Ultrasound-facilitated, catheter-directed thrombolysis beneficial in intermediate-risk PE

Cannabis may reduce risk of some skin cancers

Cannabis may reduce risk of some skin cancers

Transcatheter ViV may be a safe short-term option to repeat MVR

Transcatheter ViV may be a safe short-term option to repeat MVR

Roflumilast cream effective in Chinese patients with plaque psoriasis

Roflumilast cream effective in Chinese patients with plaque psoriasis